BioXcel Therapeutics (BTAI) Prepaid Assets (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Prepaid Assets of $3.9 million for Q1 2026, down 16.72% year-over-year from $4.7 million in Q1 2025, and down 2.06% quarter-over-quarter from $4.0 million in Q4 2025.
BioXcel Therapeutics (BTAI) Prepaid Assets (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Prepaid Assets history runs 10 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 16.72% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 16.72% YoY), while the FY2025 annual figure was $4.0 million, down 23.86% from the prior year.
- Prepaid Assets for Q1 2026 stood at $3.9 million, down from $4.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $5.3 million in Q4 2024, with the low at $934000.0 in Q3 2025.
- The 5-year median for Prepaid Assets is $3.9 million (2023), against an average of $3.4 million.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 220.82% in 2022, then plunged 63.72% in 2024.
- BioXcel Therapeutics' Prepaid Assets stood at $3.1 million in 2022, then sank by 32.25% to $2.1 million in 2023, then jumped by 154.57% to $5.3 million in 2024, then slipped by 23.86% to $4.0 million in 2025, then fell by 2.06% to $3.9 million in 2026.
- Business Quant data shows BTAI's Prepaid Assets at $3.9 million in Q1 2026, $4.0 million in Q4 2025, and $934000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.26 Mn |
| Mar 31, 2026 | 3.95 Mn |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 934,000.00 |
| Jun 30, 2025 | 5.15 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 5.29 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 3.85 Mn |
| Jun 30, 2023 | 4.64 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 4.97 Mn |
| Dec 31, 2021 | 956,000.00 |
| Sep 30, 2021 | 4.02 Mn |